Chondrus crispus carrageenan clinical trials
How each study uses Chondrus crispus carrageenan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Carraguard (PC-515)
- 6
Studies by the year they started
6 studies that test it; most in 1999 (1)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
Population Council (6)
Studies
Open first, then newest update. How each study uses Chondrus crispus carrageenan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected WomenCompletedPhase 1Population CouncilNCT00213044Written as Carraguard (PC-515)
- Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV TransmissionCompletedPhase 3Population CouncilNCT00213083Written as Carraguard (PC-515)
- Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedPhase 2Population CouncilNCT00213031Written as Carraguard (PC-515)
- Safety and Acceptability of Carraguard™ Among HIV-negative Couples in ThailandCompletedPhase 1Population CouncilNCT00213057Written as Carraguard (PC-515)
- Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI TransmissionCompletedPhase 2Population CouncilNCT00213018Written as Carraguard (PC-515)
- Safety and Acceptability of Carraguard® in HIV Positive Women and MenCompletedPhase 1Population CouncilNCT00213005Written as Carraguard (PC-515)
Codes
What other systems call Chondrus crispus carrageenan · ClinicalTrials.gg INT018119
- RxNorm 1540877One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1540877 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.